Atomoxetine treatment may decrease striatal dopaminergic transporter availability after 8 weeks: pilot SPECT report of three cases

par Akay AP, Kaya GC, Baykara B, Demir Y, Ozek H, Alsen S, Eren MS, Emiroglu NI, Ertay T, Ozturk Y, Miral S, Durak H, Tufan E
Publié 2015